These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4556413)

  • 1. A comparison between BC 105 and methysergide in the prophylaxis of migraine.
    Forssman B; Henriksson KG; Kihlstrand S
    Acta Neurol Scand; 1972; 48(2):204-12. PubMed ID: 4556413
    [No Abstract]   [Full Text] [Related]  

  • 2. [BC 105 in migraine].
    Poch GF
    Prensa Med Argent; 1972 May; 59(15):563-7. PubMed ID: 4403208
    [No Abstract]   [Full Text] [Related]  

  • 3. BC 105 and methysergide (Deseril) in migraine prophylaxis.
    Presthus J
    Acta Neurol Scand; 1971; 47(4):514-8. PubMed ID: 4941732
    [No Abstract]   [Full Text] [Related]  

  • 4. BC-105 and deseril in migraine prophylaxis. (A double-blind study).
    Andersson PG
    Headache; 1973 Jul; 13(2):71-3. PubMed ID: 4578493
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind crossover comparison of bc-105, methysergide and placebo in the prophylaxis of migraine headache.
    Ryan RE
    Headache; 1968 Oct; 8(3):118-26. PubMed ID: 4892617
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sandomigrin in migraine therapy].
    Stensrud P; Sjaastad O
    Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2443-4. PubMed ID: 4657023
    [No Abstract]   [Full Text] [Related]  

  • 7. Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.
    Speight TM; Avery GS
    Drugs; 1972; 3(3):159-203. PubMed ID: 4403890
    [No Abstract]   [Full Text] [Related]  

  • 8. [BC 105, a new preparation for migraine].
    Jorgensen RS
    Ugeskr Laeger; 1972 Oct; 134(43):2266-8. PubMed ID: 4564231
    [No Abstract]   [Full Text] [Related]  

  • 9. The prophylactic treatment of migraine with an antiserotonin pizotifen.
    Hübbe P
    Acta Neurol Scand; 1973; 49(1):108-14. PubMed ID: 4567747
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sandomigran (BC-105) in treatment of migraine and Horton's headache].
    Prusiński A; Kotwica S; Rydzewski W; Zawadzki Z
    Neurol Neurochir Pol; 1972; 6(3):427-31. PubMed ID: 5032295
    [No Abstract]   [Full Text] [Related]  

  • 11. Methysergide in migraine prophylaxis.
    Pedersen E; Moller CE
    Clin Pharmacol Ther; 1966; 7(4):520-6. PubMed ID: 5328472
    [No Abstract]   [Full Text] [Related]  

  • 12. Thermographic, hormonal, and clinical studies in migraine.
    Lance JW; Anthony M; Somerville B
    Trans Am Neurol Assoc; 1970; 95():120-4. PubMed ID: 5535242
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative trial of serotonin antagonists in the management of migraine.
    Lance JW; Anthony M
    Proc Aust Assoc Neurol; 1970; 7():31-5. PubMed ID: 4937096
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new drug in the treatment of migraine (therapeutic trial)].
    Marcos Lanzarot M
    Rev Clin Esp; 1970 Jul; 118(2):165-70. PubMed ID: 4924445
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105.
    Ekbom K
    Acta Neurol Scand; 1969; 45(5):601-10. PubMed ID: 4391566
    [No Abstract]   [Full Text] [Related]  

  • 16. Current concepts in the pathogenesis and interval treatment of migraine.
    Anthony M; Lance JW
    Drugs; 1972; 3(3):153-8. PubMed ID: 4403461
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of migraine with BC 105 (pizotifen): a double blind trial.
    Arthur GP; Hornabrook RW
    N Z Med J; 1971 Jan; 73(464):5-9. PubMed ID: 4925988
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of symptoms of patients with headaches and their response to treatment with ergot derivatives.
    Barrie MA; Fox WR; Weatherall M; Wilkinson MI
    Q J Med; 1968 Apr; 37(146):319-36. PubMed ID: 4873708
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical trial of an antiserotonin drug, bc-105 in the prophylaxis of migraine.
    Selby G
    Proc Aust Assoc Neurol; 1970; 7():37-43. PubMed ID: 4937097
    [No Abstract]   [Full Text] [Related]  

  • 20. A new agent for chemotherapy of migraine headaches: a controlled study.
    Krakowski AJ; Engisch R
    Psychosomatics; 1973; 14(5):302-8. PubMed ID: 4604015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.